Skip to main content

Table 1 Univariate and multivariate Cox regression analysis of PFS and OS

From: Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma

  PFS OS
HR(95 % CI) P value HR(95 % CI) P value
Univariate analysis  
Age 0.98(0.95-1.01) 0.148 0.99(0.96-1.02) 0.481
miR-9(high vs low) 0.43(0.24-0.77) 0.005 0.43(0.21-0.86) 0.018
Grade1, 2 vs 3 0.34(0.17-0.67) 0.002 0.26(0.11-0.64) 0.003
Stage I-II vs III-IV 0.21(0.07-0.58) 0.003 0.08(0.01-0.61) 0.015
Optimal vs Suboptimal 0.33 (0.18-0.59) 0.000 0.25 (0.13-0.51) 0.000
Type I vs Type II 0.52(0.24-1.13) 0.099 0.07(0.01-0.51) 0.009
Multivariate analysis  
miR-9 0.24(0.12-0.50) 0.000 0.37(0.18-0.76) 0.007
Stage I-II vs III-IV 0.31(0.11-0.89) 0.029 0.15(0.02-1.16) 0.069
Optimal vs Suboptimal 0.24(0.11-0.53) 0.000 0.41(0.20-0.85) 0.016
Type I vs Type II 0.87(0.38-2.01) 0.750 0.11(0.01-0.78) 0.028
  1. HR, hazard ratio; CI, confidence interval